Study of the Value of Maternal-fetal Transfers and Their Complexity of Their Implementation

NCT ID: NCT06480916

Last Updated: 2024-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-01

Study Completion Date

2025-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is an observational, descriptive, prospective, multicenter study of 8 maternity units in Lorraine and Champagne-Ardenne, aimed at comparing the percentage of "avoidable" maternal-fetal transfers (MFTs), defined as transfers in which the delivery finally meets the acceptance criteria of the sending maternity unit, according to the obstetrical indications for these MFTs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Over the past year, an audit carried out on the Mercy maternity unit, covering 130 transfers to the Nancy regional maternity hospital, showed that patients transferred for threat of premature delivery (MAP) with a cervix \> 15 mm do not give birth at the receiving maternity unit, but return home after 48 hours' hospitalization.

When maternal-fetal transfer (MFT) is requested, numerous calls are made to private ambulance services, and in the end, many emergency rapid response units (SMUR) are called out, requiring a major human, logistical and time investment for a questionable benefit to the patient. Tensions in terms of logistics (lack of ambulance, SMUR) and human resources (lack of personnel) can, conversely, compromise good care of the parturient.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Maternal-Fetal Relations

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

maternal-fetal transfer care organization patient pathway maternity hospital

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Maternal-fetal transfers

Prospective and consecutive inclusion of all maternal-fetal transfers during the study period. The teams at the sending and receiving maternity units will complete study-related questionnaires to describe the conditions of the transfer and the outcome of the pregnancy. The study in no way alters the way parturients are cared for.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant woman cared for in a participating maternity unit
* Over 18 years of age
* Requested for maternal-fetal transfer (finally performed, or not)

Exclusion Criteria

* missing data on transfer outcome
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Régional Metz-Thionville

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laetitia HONORE-ROUGE, MD

Role: PRINCIPAL_INVESTIGATOR

CHR Metz Thionville Hopital Femme Mère Enfant

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Maillot

Briey, , France

Site Status RECRUITING

Maternité CH Léon Bourgeois

Châlons-en-Champagne, , France

Site Status RECRUITING

CHR Metz Thionville Hopital Femme Mère Enfant

Metz, , France

Site Status RECRUITING

Maternité - Hôpital Maurice Camuset

Romilly-sur-Seine, , France

Site Status RECRUITING

Clinique Saint Nabor

Saint-Avold, , France

Site Status RECRUITING

Matérnité Saint Dizier

Saint-Dizier, , France

Site Status RECRUITING

CHR Metz-Thionville Hopital Bel Air

Thionville, , France

Site Status RECRUITING

Hopital Saint Nicolas

Verdun, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Arpiné EL NAR, PhD

Role: CONTACT

Phone: 0033387557766

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Arpiné EL NAR

Role: primary

Arpiné EL NAR

Role: primary

Arpiné EL NAR, PhD

Role: primary

Arpiné EL NAR

Role: primary

Arpiné EL NAR

Role: primary

Arpiné EL NAR

Role: primary

Arpiné EL NAR

Role: primary

Arpiné EL NAR

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-04Obs-CHRMT

Identifier Type: -

Identifier Source: org_study_id